Anavex Life Sciences Corp (AVXL)

[BAR123]

I will not be able to attend the shareholders meeting but I do have a few question I would like answered if someone who is attending can ask please.

1. To Dr. Missling: You have been mentioning lately that the company is preparing for commercialization, what exactly has been done to accomplish this?

2. You currently have only 37 people on board, what are the plans for hiring knowing that Rett and Alz approvals are coming soon. What will the headcount be by the EOY and the end of next year?

3. Why has it been so challenging to hit your self imposed deadlines and milestones over the years?

4. What countries will you target first to seek approval once you have the full data set complete and ready to submit for both Rett and Alz? Will Australia come first or will you always seek approval through the FDA first and then move to other countries?

5. Do you have multiple manufacturing partners lined up to produce Blarcamisine?

6. When can we expect the all important peer reviews for Alz P3 results?

7. When do you envision hiring a VP of Sales and Marketing?

8. What changed within the company that made you bring on Dr. Ma as Chairman now?

9. Why do you think the company has not gained the support of Wall Street or the scientific community with the fantastic data to date? Biogen or Lilly go up $20B in market cap on their data and we go down with ours. Any thoughts on this phenomenon?

10. You have always said that the company will need to partner for the large indications like Alz and Parkinson's, do you still feel that way or would you be open to a buyout if the price is right? What is the right price?

Thank you.